Deerfield Management Company, L.P. 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Deerfield Management Company, L.P. disclosed 122 US equity positions worth $5.0bn in its Q1 2025 13F filing. The largest position was NUVALENT INC at 25.3% of the reported book, followed by VTRS and INTEGRA LIFESCIENCES HLDGS C. Against the Q4 2024 filing, it opened 8 new positions, added to 12 and reduced 5 among the top 50 holdings.
What did Deerfield Management Company, L.P. own in Q1 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | NUVALENT INC | 25.3% | $1.3bn | 17,991,024 | 0% | held | |
| 2 | VTRS VIATRIS INC | Healthcare | 4.1% | $209.0m | 23,991,594 | -0% | held |
| 3 | INTEGRA LIFESCIENCES HLDGS C | 3.4% | $171.0m | 174,364,000 | 0% | held | |
| 4 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 3.3% | $164.7m | 1,489,000 | 73% | added |
| 5 | CNC CENTENE CORP DEL | Healthcare | 3.2% | $162.2m | 2,671,921 | 0% | held |
| 6 | OSCR OSCAR HEALTH INC | Healthcare | 3.1% | $155.2m | 11,840,818 | 0% | held |
| 7 | MERUS N V | 2.6% | $133.6m | 3,173,928 | 7% | added | |
| 8 | SPRY ARS PHARMACEUTICALS INC | Healthcare | 2.6% | $132.3m | 10,514,657 | 0% | held |
| 9 | ACCOLADE INC | 2.6% | $130.6m | 132,598,000 | 0% | held | |
| 10 | ALNY ALNYLAM PHARMACEUTICALS INC | 2.5% | $126.9m | 110,000,000 | 0% | held | |
| 11 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.3% | $117.3m | 3,317,332 | 2% | added |
| 12 | MIRM MIRUM PHARMACEUTICALS INC | 2.3% | $114.5m | 70,000,000 | 0% | held | |
| 13 | AHCO ADAPTHEALTH CORP | Healthcare | 2.1% | $105.3m | 9,711,410 | 0% | held |
| 14 | INDIVIOR PLC | 2.0% | $100.7m | 10,567,160 | 19% | added | |
| 15 | BKD BROOKDALE SR LIVING INC | Healthcare | 1.9% | $97.7m | 15,612,264 | 0% | held |
| 16 | ALHC ALIGNMENT HEALTHCARE INC | Healthcare | 1.7% | $85.0m | 4,567,473 | -37% | reduced |
| 17 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 1.7% | $84.8m | 275,226 | – | new |
| 18 | PFE PFIZER INC | Healthcare | 1.7% | $84.8m | 3,347,296 | – | new |
| 19 | NEWAMSTERDAM PHARMA COMPANY | 1.7% | $84.0m | 4,103,957 | -5% | reduced | |
| 20 | CATALYST PHARMACEUTICALS INC | 1.6% | $83.0m | 3,422,149 | 9% | added | |
| 21 | DVAX DYNAVAX TECHNOLOGIES CORP | 1.3% | $67.3m | 5,191,493 | -0% | held | |
| 22 | BAX BAXTER INTL INC | Healthcare | 1.3% | $65.8m | 1,923,100 | 0% | held |
| 23 | LEGN LEGEND BIOTECH CORP | Healthcare | 1.2% | $59.2m | 1,743,555 | 12% | added |
| 24 | BIO BIO RAD LABS INC | Healthcare | 1.1% | $55.1m | 226,070 | 49% | added |
| 25 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 1.1% | $53.5m | 3,267,551 | 19% | added |
| 26 | EWTX EDGEWISE THERAPEUTICS INC | 0.9% | $45.7m | 2,078,509 | 0% | held | |
| 27 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 0.9% | $45.6m | 21,231,974 | 0% | held |
| 28 | ENHABIT INC | 0.9% | $43.9m | 4,997,746 | -0% | held | |
| 29 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.8% | $39.2m | 145,000 | -0% | held |
| 30 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.8% | $38.9m | 5,189,665 | -36% | reduced |
| 31 | IRON DISC MEDICINE INC | Healthcare | 0.8% | $38.8m | 782,333 | 30% | added |
| 32 | CNMD CONMED CORP | Healthcare | 0.7% | $36.9m | 611,000 | -0% | held |
| 33 | LANTHEUS HLDGS INC | 0.7% | $35.6m | 25,255,000 | 0% | held | |
| 34 | NVST ENVISTA HOLDINGS CORPORATION | Healthcare | 0.7% | $35.0m | 2,024,943 | 99% | added |
| 35 | INSM INSMED INC | Healthcare | 0.7% | $34.9m | 458,000 | – | new |
| 36 | EMBC EMBECTA CORP | Healthcare | 0.7% | $34.7m | 2,720,535 | -17% | reduced |
| 37 | CMRXEUR CHIMERIX INC | 0.6% | $32.1m | 3,771,342 | 0% | held | |
| 38 | PHVS PHARVARIS N V | 0.6% | $31.7m | 2,017,464 | 0% | held | |
| 39 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.6% | $29.2m | 3,860,839 | 14% | added |
| 40 | INMD INMODE LTD | Healthcare | 0.6% | $28.0m | 1,578,708 | 0% | held |
| 41 | PHR PHREESIA INC | Healthcare | 0.5% | $25.8m | 1,009,844 | -21% | reduced |
| 42 | VERA VERA THERAPEUTICS INC | Healthcare | 0.5% | $25.2m | 1,050,000 | – | new |
| 43 | IMMUNOCORE HLDGS PLC | 0.5% | $25.2m | 30,000,000 | – | new | |
| 44 | LQDA LIQUIDIA CORPORATION | Healthcare | 0.5% | $23.8m | 1,616,778 | – | new |
| 45 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.5% | $23.5m | 2,960,740 | 14% | added | |
| 46 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.5% | $23.5m | 619,931 | – | new |
| 47 | LNTH LANTHEUS HLDGS INC | Healthcare | 0.5% | $23.4m | 240,218 | 0% | held |
| 48 | SVRA SAVARA INC | Healthcare | 0.4% | $22.1m | 7,964,000 | 0% | held |
| 49 | CGON CG ONCOLOGY INC | Healthcare | 0.4% | $20.8m | 850,695 | -0% | held |
| 50 | CERT CERTARA INC | Healthcare | 0.4% | $20.0m | 2,022,616 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.